Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...
GCC Syringes and Needles MarketThe market for syringes and needles in the Gulf Cooperation Council (GCC) region is poised for ...
InsuJet [is] the first device to Canada that actually has no needles,” said Daphne Lapenna of Sol-Millennium Medical Ltd. who ...
Insulet’s Omnipod 5 automated insulin delivery (AID) system has multiple avenues to expand as it has revolutionized the way patients treat their diabetes, including the new indication for Type 2 ...
Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, Sanofi, and all insulin manufacturers to take urgent action to increase access ...
One of the primary drivers is the increasing need for prefilled syringes, which are preferred for their convenience, safety, and ease of use, especially in self-administration of medications like ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
A rogue B.C. acupuncturist has been found in contempt of court for practising unlicensed needlework. A B.C. Supreme Court ...
Report Ocean, a leading strategic consulting and market research firm, in its recent study, estimated India Prefilled Syringes Market size by value at USD 1.13 billion in 2023. During the forecast ...
The Global Needle Free Injectors Market is projected to grow from USD 1,478.9 Million in 2024 to USD 2,980.9 Million by 2033, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback